SAN JOSE, Calif., – January 20, 2026 (Globe Newswire) – BrightInsight, Inc., a leader in digital health solutions, today announced a new investment round of $13 million from existing and new investors including Eclipse, General Catalyst, Insight Partners, Mayo Clinic, and New Leaf Venture Partners. This new capital will accelerate development of BrightInsight’s AI-enabled medication persistence and adherence solutions and enable rapid scalability of high-impact programs, such as the Patient App from its collaboration with Sanofi and their partner, Regeneron, across a broad range of diseases and therapies globally.

Read more here.